Oncology Central

How safe is chemotherapy and chemoradiation in elderly patients with small-cell lung cancer?

0

Small-cell lung cancer (SCLC) accounts for approximately 15% of all lung cancers. Approximately 70% of all newly diagnosed patients with SCLC are 60 years of age or older, and more than 30% are even more than 75 years of age [1]. Since smoking is the major risk factor for SCLC, the majority of elderly SCLC patients have serious comorbid conditions besides SCLC, especially smoking-related diseases, such as cardiovascular diseases, chronic obstructive pulmonary diseases and other cancers [2,3].

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.

Share:

Insights

Videos

News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.